These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 11683345
21. Pathogenesis of Wegener's granulomatosis. Gross WL, Trabandt A, Csernok E. Ann Med Interne (Paris); 1998 Sep; 149(5):280-6. PubMed ID: 9791561 [Abstract] [Full Text] [Related]
22. Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener's granulomatosis. Feng Z, Liu P, Li Z, Sui B. J Clin Lab Anal; 2008 Sep; 22(1):73-6. PubMed ID: 18200577 [Abstract] [Full Text] [Related]
23. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Holland M, Takada K, Okumoto T, Takahashi N, Kato K, Adu D, Ben-Smith A, Harper L, Savage CO, Jefferis R. Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039 [Abstract] [Full Text] [Related]
24. Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis. Baslund B, Szpirt W, Eriksson S, Elzouki AN, Wiik A, Wieslander J, Petersen J. Eur J Clin Invest; 1996 Sep; 26(9):786-92. PubMed ID: 8889441 [Abstract] [Full Text] [Related]
25. High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement. Westman KW, Selga D, Isberg PE, Bladström A, Olsson H. J Am Soc Nephrol; 2003 Nov; 14(11):2926-33. PubMed ID: 14569103 [Abstract] [Full Text] [Related]
26. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS). Kidney Int; 2002 Jan; 61(1):80-9. PubMed ID: 11786087 [Abstract] [Full Text] [Related]
27. Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener’s granulomatosis. Bruner BF, Vista ES, Wynn DM, Harley JB, James JA. Clin Exp Immunol; 2010 Nov; 162(2):262-70. PubMed ID: 21077276 [Abstract] [Full Text] [Related]
28. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A, Neil J, Pollock W, Dunster K, Hendle M. J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813 [Abstract] [Full Text] [Related]
29. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. Sun J, Fass DN, Hudson JA, Viss MA, Wieslander J, Homburger HA, Specks U. J Immunol Methods; 1998 Feb 01; 211(1-2):111-23. PubMed ID: 9617836 [Abstract] [Full Text] [Related]
30. Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA). Wang G, Csernok E, de Groot K, Gross WL. J Immunol Methods; 1997 Oct 27; 208(2):203-11. PubMed ID: 9433475 [Abstract] [Full Text] [Related]
31. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients. Harper L, Radford D, Plant T, Drayson M, Adu D, Savage CO. Arthritis Rheum; 2001 Apr 27; 44(4):921-30. PubMed ID: 11315931 [Abstract] [Full Text] [Related]
32. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL. Rheumatology (Oxford); 2004 Feb 27; 43(2):174-80. PubMed ID: 14585921 [Abstract] [Full Text] [Related]
33. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies. van der Geld YM, Oost-Kort W, Limburg PC, Specks U, Kallenberg CG. J Immunol Methods; 2000 Oct 20; 244(1-2):117-31. PubMed ID: 11033024 [Abstract] [Full Text] [Related]
34. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA). Specks U, Wiegert EM, Homburger HA. Clin Exp Immunol; 1997 Aug 20; 109(2):286-95. PubMed ID: 9276524 [Abstract] [Full Text] [Related]
35. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. Rarok AA, Stegeman CA, Limburg PC, Kallenberg CG. J Am Soc Nephrol; 2002 Sep 20; 13(9):2232-8. PubMed ID: 12191967 [Abstract] [Full Text] [Related]
36. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Radice A, Vecchi M, Bianchi MB, Sinico RA. Clin Exp Rheumatol; 2000 Sep 20; 18(6):707-12. PubMed ID: 11138332 [Abstract] [Full Text] [Related]
37. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Mayet WJ, Meyer zum Büschenfelde KH. Clin Exp Immunol; 1993 Dec 20; 94(3):440-6. PubMed ID: 7504599 [Abstract] [Full Text] [Related]
38. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA). Selak S, Woodman RC, Fritzler MJ. Clin Exp Immunol; 2000 Dec 20; 122(3):493-8. PubMed ID: 11122260 [Abstract] [Full Text] [Related]
39. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, Wieslander J. Kidney Int; 1998 May 20; 53(5):1230-6. PubMed ID: 9573537 [Abstract] [Full Text] [Related]
40. Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha). Moosig F, Csernok E, Kumanovics G, Gross WL. Clin Exp Immunol; 2000 Dec 20; 122(3):499-503. PubMed ID: 11122261 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]